Why Co-Diagnostics Skyrocketed 28.3% Today

Why Co-Diagnostics Skyrocketed 28.3% Today

What happened After the Food and Drug Administration approved collaboration partner Clinical Reference Laboratory's saliva test for COVID-19, Co-Diagnostics (NASDAQ: CODX) shares soared 28.3% on Monday.